Herold Advisors, Inc. Amarin Corp Plcuk Transaction History

Herold Advisors, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 15, 2022	SELL	$1.13 - $3.69 $903 - $2,952	-800 Closed	0 $0
Q1 2022 May 09, 2022	BUY	$2.85 - $3.73 $2,280 - $2,984	800 New	800 $2,000
Q4 2021 Jan 20, 2022	SELL	$3.24 - $5.18 $2,592 - $4,144	-800 Closed	0 $0
Q3 2021 Nov 03, 2021	BUY	$3.94 - $5.84 $3,152 - $4,672	800 New	800 $4,000

177

69.9M

258K

98K

Ticker AMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 403,206,016
Market Cap $246M
Description
Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...

Get notified when there are updates to the investment portfolio of Herold Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Herold Advisors, Inc. with notifications on news.